Pub. L. 118-31, div. A, tit. VII, subtit. A, sec. 706 (as amended)

NALOXONE AND FENTANYL: REGULATIONS; BRIEFING.

Year: 2025Length: 207 wordsOfficial source
SEC. 706. [10 U.S.C. 1090 note] NALOXONE AND FENTANYL: REGULATIONS; BRIEFING. (a) Regulations.—Not later than January 1, 2025, the Secretary of Defense, in coordination with the Secretaries of the military departments shall prescribe regulations regarding naloxone and fentanyl on military installations. Such regulations shall— (1) ensure that naloxone is available for members of the Armed Forces— (A) on all military installations; and (B) in each operational environment; and (2) establish a standardized tracking system— (A) for naloxone distributed under paragraph (1); and (B) of the illegal use of fentanyl and other controlled substances in the military departments. (b) Briefing.—Not later than June 1, 2025, the Secretary of Defense shall submit to the Committees on Armed Services of the Senate and House of Representatives a briefing regarding naloxone and fentanyl. Such briefing shall include the following elements: (1) Progress in the implementation of regulations prescribed under subsection (a). (2) The prevalence and incidence of the illegal use of fentanyl and other controlled substances in the military departments during the five years preceding the briefing. (3) Processes of the military departments to mitigate substance abuse, particularly with regards to fentanyl. (c) Naloxone Defined.—In this section, the term “naloxone” means naloxone and any other medication used to reverse opioid overdose.
Cross-references to the US Code
10 U.S.C. 1090 note
Pub. L. 118-31, div. A, tit. VII, subtit. A, sec. 706 (as amended): NALOXONE AND FENTANYL: REGULATIONS; BRIEFING. | Justis AI